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Abstract
Myocardial infarction and sudden cardiac death are 
frequently the first manifestation of coronary artery 
disease. For this reason, screening of asymptomatic 
coronary atherosclerosis has become an attractive field 
of research in cardiovascular medicine. Necropsy studies 
have described histopathological changes associated 
with the development of acute coronary events. In this 
regard, thin-cap fibroatheroma has been identified as 
the main vulnerable coronary plaque feature. Hence, 
many imaging techniques, such as coronary computed 
tomography, cardiac magnetic resonance or positron 
emission tomography, have tried to detect noninvasively 
these histomorphological characteristics with different 
approaches. In this article, we review the role of these 
diagnostic tools in the detection of vulnerable coronary 
plaque with particular interest in their advantages and 
limitations as well as the clinical implications of the 
derived findings.
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Core tip: Noninvasive diagnosis of vulnerable coronary 
plaque has become of major interest in preventive 
cardiology. Certain histological features have been 
related with an increased risk of plaque rupture. Coro-
nary computed tomography has been largely used for 
this aim, and some lesion characteristics have been 
consistently associated with acute coronary syndrome 
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in several studies. Moreover, a growing body of 
evidence suggests the potential role of cardiac magnetic 
resonance and positron emission tomography in high-
risk lesion detection. These promising results should 
be put in perspective to select the high-risk population 
that may benefit the most from the use of coronary 
vulnerable plaque imaging screening.
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INTRODUCTION
Atherosclerosis constitutes the leading cause of 
morbidity and mortality in the developed countries, 
mostly secondary to acute coronary syndromes (ACS)[1]. 
Moreover, the progressive aging of the population 
forecasts an exponential growth of the prevalence 
of cardiovascular disease[2]. In this clinical scenario, 
detection of patients at risk of suffering an ACS has 
become one of the major goals in cardiology. Traditional 
cardiovascular risk factors have been extensively used 
for this aim. Nevertheless, they fail to anticipate the 
occurrence of an ACS, especially in certain popula­
tions[3,4], so myocardial infarction and sudden cardiac 
death (SCD) are frequent first manifestations of 
coronary disease. This situation has boosted the interest 
in subclinical detection of atherosclerosis. In this regard, 
quantification of calcium score with coronary computed 
tomography (CCT)[5] as well as ultrasound evaluation 
of carotid atherosclerosis[6,7] have demonstrated their 
utility for cardiovascular risk reclassification[8,9]. In any 
case, in spite of a very common detection of coronary 
atherosclerosis in autopsy series among young adults[10] 
the incidence of ACS in this population is very low[1]. 
Thus, the onus should be shifted onto the detection of 
lesions that are prone to develop a coronary event.
VULNERABLE CORONARY PLAQUE: 
DEFINITION, HISTOPATHOLOGICAL 
FEATURES AND RATIONALE FOR 
NONINVASIVE DIAGNOSIS
Classical studies supported that ACS were caused 
mainly by lesions with severe stenosis[11]; however, 
PROSPECT trial[12], a prospective intravascular ultra­
sound (IVUS) and virtual histology (VH) follow­up of 
non­culprit lesions after ACS, revealed that most of the 
events are derived from angiographically mild stenosis 
(< 50%). Again autopsy studies have provided relevant 
information regarding the atherosclerotic plaque 
characteristics in culprit lesions. The most frequent 
presentation is plaque rupture, followed by plaque 
erosion[13]. Rarely (2%­7% of the cases) the ACS are 
related with a calcified nodule morphology[14]. These 
lesions are unfailingly associated with a variable amount 
of thrombus[15]. Given that plaque rupture is the most 
common substrate of acute coronary events, vulnerable 
plaques are defined as lesions at the greatest risk of 
rupture, with subsequent thrombosis or rapid stenosis 
progression (Table 1)[16]. Therefore, they are also 
named high­risk or thrombosis­prone plaques.
When ruptured plaques leading to acute coronary 
events were studied in necropsies, they usually presented 
a large necrotic core with a thin overlying fibrous cap 
together with inflammatory cells and little calcification[17]. 
Moreover, unlike lesions related to stable disease, these 
plaques showed expansive or positive remodeling not 
causing significant narrowing of the coronary lumen[18]. 
Thus, plaques with these histomorphologic features 
but intact fibrous cap, named thin­cap fibroatheroma 
(TCFA), were assumed to be prone to rupture. This 
concept was evaluated in a detailed histologic analysis 
of atherosclerotic plaques from a large series of patients 
who suffered SCD[19]. This study established a relevance 
hierarchy of morphological features that may influence 
plaque rupture. In a general analysis a thin fibrous cap (< 
84 μm) was able to exclude stable lesions. Interestingly, 
among TCFA with a cap thickness < 54 μm cross­
section area stenosis was most likely < 74%. Finally, 
when fibrous cap thickness was not considered in the 
analysis, inflammation, characterized by macrophage 
plaque infiltration, as well as a large necrotic core 
emerged as typical features of potentially unstable 
lesions. In this regard, aforementioned PROSPECT 
trial[12] was able to confirm these findings in vivo with 
IVUS. In this study plaque burden ≥ 70%, minimal 
luminal area ≤ 4 mm2 and TCFA characteristics on VH 
were independently associated with subsequent major 
adverse cardiovascular events (MACE) derived from 
non­culprit lesions.
Some considerations should be kept in mind to 
understand the clinical relevance of vulnerable plaque 
detection. All the plaque ruptures do not inevitably 
cause an ACS[20], whereas disruption and healing is the 
typical mechanism of plaque stenosis growth[21,22]. Thus, 
a perfect storm scenario, with confluence of plaque 
vulnerability, inflammatory state, platelet activation and 
impaired fibrinolysis, is necessary for ACS occurrence[23]. 
However, given that substrate presence is a conditio 
sine qua non and the other involved factors (homeostasis 
disbalance and thrombogenicity) are difficult to esta­
blish and/or variable in time, noninvasive detection 
of vulnerable plaques may be clinically relevant[24], 
especially in very high risk patients[25]. 
Hence, in this paper we review the different noninva­
sive diagnostic tools to evaluate vulnerable coronary 
plaques, with a detailed description of the relevant 
information they provide as well as their particular 
strengths and limitations (Table 2). We focus specially 
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on the technique with the greatest evidence in this 
field, CCT, mentioning other available imaging tools 
with promising perspective such as cardiac magnetic 
resonance (CMR) imaging and positron emission tomo­
graphy (PET).
CCT 
CCT general information with predictive value 
CCT not only provides information about the presence 
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of significant stenoses with a high diagnostic accuracy[26] 
(Figure 1) but also allows a sensitive noninvasive direct 
evaluation of coronary atherosclerosis[27]. Coronary 
calcium score determination[28] as well as non-calcified 
plaque detection, even in the absence of significant 
stenosis[29­31], have demonstrated their value to predict 
MACE. Moreover, a large and systematic meta­analysis 
highlighted the relevance of luminal stenosis severity 
assessment with CCT[32], showing an increasing risk of 
the composite end­point of cardiac death or myocardial 
  Culprit lesion Coronary lesion considered to be responsible for the clinical event, usually plaque complicated by intraluminal 
thrombosis
  Thrombosed plaque Plaque with an overlying thrombus extending into the vessel lumen either occlusive or non-occlusive
  Eroded plaque Thrombosed plaque (mainly fibrotic or proteoglycan-rich) due to loss or dysfunction of endothelial cells without 
associated rupture
  Plaque with calcified nodule Heavily calcified protruding plaque with loss or dysfunction of endothelial cells
  Vulnerable, high-risk or thrombosis 
  prone plaque
Plaque at increased risk of thrombosis and rapid stenosis progression
TCFA: Inflamed plaque with a thin cap covering a lipid-rich necrotic core
  Vulnerable patient Patient at high-risk to experience a cardiovascular ischemic event due to a high atherosclerotic burden, high-risk 
plaques and/or thrombogenic blood
Table 1  Concepts related to vulnerable coronary plaque[16]
TCFA: Thin-cap fibroatheroma.
A B C
Figure 1  Coronary computed tomography stenosis evaluation compared with invasive coronary angiography. Case of a patient with 3-vessel disease. 
Maximum intensity projection CCT findings are shown in the upper row with the corresponding ICA projections in the lower row. (A) demonstrates a significant 
stenosis in the ostium of the diagonal branch (arrow) at the level of its take-off from the mid-LAD in both CCT and ICA (D); In (B) CCT shows a subtotal occlusion 
in the proximal LCx (red arrow) that corresponds to a critical lesion at the same level in ICA (E); In CCT image from (C) a mixed plaque is detected in proximal RCA 
causing a significant stenosis (arrowhead), as corroborated by ICA (F). CCT: Coronary computed tomography; ICA: Invasive coronary angiography; LAD: Left anterior 
descending coronary artery; LCx: Left circumflex coronary artery; RCA: Right coronary artery.
Pozo E et al . Vulnerable plaque diagnosis
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Coronary plaque characterization with CCT
Certainly, the most relevant information is derived from 
the direct evaluation of coronary plaque with CCT. By 
consensus[35] the lesions are classified in 3 categories: 
Non­calcified, calcified and mixed plaques (Figure 
2). In this regard, for a further assessment of CCT 
infarction for absence (0.04%), non­obstructive (1.29%) 
and obstructive (6.53%) coronary artery disease. It 
has shown a particular utility in chest pain evaluation at 
the emergency room[33]. There is also data supporting 
the capacity of CCT to evaluate coronary anatomy to 





Figure 2  Coronary plaque categories by coronary computed tomography. Patient with chest pain referred for CCT. A: LAD in multiplanar reconstruction with a 
mixed plaque in the mid segment (arrow) that causes significant stenosis confirmed in the ICA (B, arrow). Note that there is also a nonsignificant noncalcified plaque 
in the proximal segment (red arrow) that is barely seen in coronariography (B, red arrow); C: A maximum intensity projection that demonstrates a severely calcified 
plaque in the ostial RCA (arrowhead), which does not allow luminal stenosis evaluation. However, ICA (D) confirms the absence of significant stenosis at the same 
level (arrowhead). CCT: Coronary computed tomography; LAD: Left anterior descending coronary artery; ICA: Invasive coronary angiography; RCA: Right coronary 
artery.
CCT CMR PET
  Plaque 
  characterization
Plaque morphology Plaque morphology
Tissue characterization of plaque
Inflammation (FDG)
Macrophage infiltration (new tracers)








  Clinical relevance Strong association with ACS
Prediction of slow-flow after PCI
Evaluation of response to statins
Initial data of association of T1 hyperintense 
plaques with slow-flow, ACS and response to 
statins
Differentiation between ACS and stable 
coronary disease
  Limitations Radiation exposure
Heavy calcification
Overlap in attenuation ranges
Inability to detect plaque erosion
Direct relation between spatial resolution and 
acquisition time
Susceptibility to motion artifacts
Low spatial and temporal resolution
Myocardial background uptake
Expensive and limited availability
Table 2  Diagnostic tests for noninvasive evaluation of coronary vulnerable plaque
CCT: Coronary computed tomography; CMR: Cardiac magnetic resonance; PET: Positron emission tomography; ACS: Acute coronary syndrome; PCI: 
Percutaneous coronary intervention; FDG: Fluorodeoxyglucose.
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erosions leading to ACS from stable lesions. Lastly, CCT 
accuracy for plaque composition characterization was 
also evaluated with near­infrared spectroscopy (NIRS), 
showing a good correlation of plaque burden and non­
calcified plaque area and density with cholesterol 
deposition in the coronary wall[27].
Thereby, even with first generation 16­rows scan­
ners, culprit lesion characteristics could be evaluated 
in ACS[44]. When these lesions were compared with 
those in patients with stable angina, positive expansive 
remodeling, low attenuation (< 30 HU) non­calcified 
plaques and spotty calcification were detected more 
frequently (Figure 3). Furthermore, the combination of 
these three features increased the positive predictive 
value to 95%. These findings were corroborated with 
a prospective multimodal imaging protocol in acute 
coronary events[45]. Again lower radiological density with 
lower calcium score and larger remodeling index were 
more common in culprit lesions. Interestingly, these 
plaque characteristics were confirmed with IVUS and 
VH.
Beyond the classical tools for CCT analysis, there 
are new approaches with promising results in coronary 
plaque evaluation. Fujimoto et al[46] showed that the 
presence of delayed plaque enhancement in serial 
CCT acquisition was associated with high­risk plaque 
features. They hypothesized that this finding may be 
explained by plaque neovascularization and/or inflam-
mation. In the same direction, a contrast agent formed 
by iodinated nanoparticles has been probed to detect 
macrophages in a preclinical model of atherosclerosis[47].
accuracy in coronary plaque qualitative analysis, head­
to­head comparisons with VH have been performed. 
Pundziute et al[36] found a good correlation between 
both diagnostic tools in plaque characterization, with 
more fibrotic and fibro­fatty components in non­
calcified plaque. Besides, the majority of TCFA in IVUS 
corresponded to mixed plaques in CCT. Hereof, Choi 
et al[37] established that plaques with > 10% necrotic 
core by VH showed significantly lower HU values in 
CCT. All the studies have shown a good agreement 
in non­calcified plaque quantification between both 
techniques[38­40]. However, there were contradictory 
results in plaque composition analysis using predefined 
Hounsfield unit (HU) ranges, due to overlapping in 
these values[38,40]. On the other hand, optical coherence 
tomography (OCT) has also been used as reference 
intravascular imaging technique. Kashiwagi et al[41] 
divided plaques in TCFA and non­TCFA according to OCT 
findings and studied the CCT plaque characteristics. 
Positive remodeling, lower attenuation values and ring­
like enhancement (napkin­ring sign) on CCT were 
significantly more common in OCT-derived TCFA lesions. 
The later feature showed a good diagnostic accuracy 
for high­risk plaque detection and was independently 
associated with acute events. Moreover, napkin­ring sign 
has been independently associated with necrotic/lipid 
core area, non­core plaque area and total vessel area in 
post­mortem histopathological correlation[42]. However, 
although the presence of low attenuation and positive 
remodeling in CCT could identify rupture plaques in 




Figure 3  Vulnerable coronary plaque features by coronary computed tomography. Patient with unstable angina who underwent CCT followed by ICA. A severe 
stenosis (arrows) in mid-LAD just before the origin of the second diagonal was detected in CCT (A) and subsequently confirmed by ICA (B); A detailed analysis of 
multiplanar reconstruction of CCT (C) revealed the presence of positive remodeling (red arrow) and low attenuation (arrow head) at the level of the culprit lesion, both 
signs associated with vulnerable coronary plaque. CCT: Coronary computed tomography; ICA: Invasive coronary angiography; LAD: Left anterior descending coronary 
artery.
Pozo E et al . Vulnerable plaque diagnosis
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differences in lumen volume and remodeling index 
changes between the groups. Thus, CCT may play a role 
in evaluation of the response to lipid­lowering drugs.
Limitations of CCT in coronary plaque evaluation
Despite the promising data, CCT is far from be free 
of limitations in vulnerable coronary plaque analysis. 
First, precise definition of plaque components is ham-
pered by inherent limited spatial resolution of this 
imaging technique. Thus, results of non-calcified plaque 
quantification may be inconsistent[39,57]. Moreover, as 
previously mentioned, CCT plaque characterization 
is restricted by the overlap in radiological attenuation 
ranges for the different types of lesions[58,59] (Figure 
4). In this regard, dual­source CCT, whose 2 different 
energies provide differing attenuation of materials, 
have shown to improve differentiation of necrotic core 
and fibrous plaque ex vivo[60]. Nevertheless, these 
results worsened when applied in vivo[38,60]. Thus, CCT 
acquisition technology needs to be refined to establish 
a generalizable HU­based categorization for accurate 
evaluation of components of the coronary plaque. 
Second, heavily calcified plaque may obscure detailed 
plaque evaluation due to partial volume effect. Finally, 
as previously mentioned, CCT has failed to detect 
plaque erosion[43], which constitutes the second more 
frequent presentation of culprit lesions[13]. 
CMR 
CMR not only allows a precise ventricular volume 
quantification[61] and myocardial tissue characteri­
zation[62,63], but also is able to detect the presence of 
significant (> 50%) coronary atherosclerosis with similar 
accuracy than CCT[64,65] (Figure 5). In any case, in CMR 
spatial resolution is directly proportional to scan time. 
Thus, the necessary high resolution for coronary imaging 
carries an inherent increased susceptibility to motion 
artifacts[66]. The most effective measure to optimize 
image resolution without affecting artifact susceptibility 
is to reduce the field of view[67], which is difficult if a 
whole coronary tree analysis is pursued. Apart from 
that, several strategies have been implemented to avoid 
aforementioned limitation: Techniques to accelerate 
image acquisition[68,69], cardiac[70] and respiratory[71] 
motion compensation and new sampling methods[72,73]. 
However, even with the last technical advances a whole­
heart coronary CMR angiography still takes at least 5 
min[74,75], which limits its translation to clinical practice.
Although the aforementioned limitations make 
the acquisition challenging, non­contrast black­blood 
sequences have shown a good correlation with IVUS 
in luminal area and coronary plaque burden deter­
mination[76,77]. Interestingly, methemoglobin produced 
during clot maturation has the potential of shortening 
T1 relaxation time, which allows coronary thrombus 
detection with T1­weighted sequences[78,79]. The dia­
gnostic accuracy of this noninvasive technique was 
Prognostic relevance of plaque characterization with 
CCT
The hypothesis that aforementioned morphological 
patterns are able to identify thrombosis­prone plaques 
was evaluated in prospective studies. Motoyama et al[48] 
analyzed for the first time CCT plaque characteristics 
associated with the incidence of ACS in the follow­
up. In this study, the presence of positive remodeling 
and/or low attenuation plaque was independently 
associated with ACS (HR = 22.8; P < 0.001) (Figure 
3). Napkin­ring sign is another feature that has been 
associated with thrombosis­prone plaque. In a large 
series this sign was the strongest predictor of ACS 
among the vulnerable plaque characteristics[49]. On the 
other hand, a case­control study[50] demonstrated that 
when a semiautomated quantitative analysis of CCT 
was implemented, total and relative plaque volume 
and non­calcified plaque were significantly higher in 
patients who suffered an acute coronary event. This 
method of evaluation also had additive value to classical 
cardiovascular risk factors and conventional CCT reading 
for ACS prediction. Nevertheless, on top of the some 
methodological limitations[51], there is contradictory 
results in large prospective series. Among patients 
derived from ROMICAT II cohort[52], acute chest pain in 
emergency room, presence of a least one of high risk 
features (positive remodeling, low attenuation, spotty 
calcification and napkin-ring sign) was an independent 
predictor of ACS, even after adjustment by clinical risk 
factors and > 50% or > 70% stenosis[52]. Conversely, 
when stable patients were evaluated, plaque feature 
analysis, although improved predictive accuracy, did 
not significantly increase model discrimination index for 
acute coronary events[53]. Interestingly, the relevance 
of high­risk plaque detection on CCT was analyzed in 
another important cohort from a patient­based and 
lesion­based perspective[54]. In the former, vulnerable 
plaque was independently associated with prognosis. 
However, presence of high­risk features failed to predict 
ACS in a lesion­based analysis. Additionally, when serial 
CCT was available, plaque progression emerged as an 
independent predictor of events. Putting all these data 
in perspective, although vulnerable plaque CCT features 
may predict ACS the clinical relevance of these finding 
still needs to be clarify.
Influence of CCT plaque characteristics in percutane-
ous coronary interventions outcome was evaluated 
as well. The incidence of slow­flow phenomenon in 
patients with stable coronary disease was related with 
the presence of circumferential plaque calcification, a 
higher positive remodeling index and a lower plaque 
density in previous CCT[55]. In fact, circumferential 
plaque calcification showed the strongest independent 
association with this complication.
Finally, when CCT was used to evaluate the response 
to statin therapy[56] a greater decrease of total plaque 
volume, due to reduction in low attenuation plaque, 
was detected among patients under treatment, without 
Pozo E et al . Vulnerable plaque diagnosis
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large animals and/or humans: Fibrin-specific[88­90] and 
elastin­specific[91] contrast agents, gadofluorine[92,93], 
albumin­binding[94­96] contrast agent, and iron oxide­
based[97] contrast. However, due to the growing field of 
molecular imaging a detailed discussion of these agents 
exceed the scope of this review.
PET
Besides the detailed morphological characterization 
provided by CCT and CMR, quantification of inflam­
mation is a key feature in vulnerable coronary plaque 
evaluation. In this regard, nuclear imaging techniques 
have been extensively used for this purpose in 
atherosclerosis[98,99]. PET is the preferred tool, due to its 
superior spatial resolution over single photon emission 
tomography (SPECT), and is usually combined with 
computed tomography for a better anatomical definition. 
Fluorodeoxyglucose (FDG) is the most widely used tracer 
in this field. However, coronary evaluation is hampered 
by the significant myocardial uptake of FDG. To override 
this limitation, free fatty myocardial metabolism was 
favored with a low­carbohydrate high fat preparation[100]. 
This strategy was initially proven to detect coronary 
plaque inflammation[101]. Moreover, when coronary 
PET was evaluated in ACS as well as in stable angina 
proven to be high when it was evaluated against inva­
sive coronary angiography[80] and OCT[81] (Figure 6). 
On the other hand, in a head­to­head comparison 
with CCT the presence of high intensity lesions on T1 
sequences was associated with features of vulnerable 
plaque, such as positive remodeling, low attenuation 
and spotty calcification[82]. Moreover, this CMR finding 
was also associated with prognosis: Higher incidence 
of slow­flow phenomenon after percutaneous coronary 
intervention[82], coronary events during the follow­up[83], 
and regression of plaque in response to statin therapy[84]. 
Finally, T2­weighted sequences have demonstrated 
their ability to detect coronary vessel wall edema, in 
probable relation with plaque neovascularization, in initial 
studies[85,86].
Targeted as well as non­targeted contrast agents 
have been used to evaluate coronary arteries with 
CMR. When nonspecific gadolinium contrast is used, the 
presence of hyperenhancement has been linked to the 
severity of coronary atherosclerosis[79]. Additionally, a 
progressive reduction of coronary hyperenhancement 
has been noted in serial CMR after acute myocardial 
infarction[87]. Contrarily, many targeted contrast agents, 
directed to specific components of the plaque, are 
currently under investigation. Among them some have 
already reached positive data for coronary evaluation in 
Pozo E et al . Vulnerable plaque diagnosis
Figure 4  Coronary computed tomography characterization of plaque components. Multimodal evaluation of a mid-LAD lesion in bifurcation with a Dx branch. 
A: CCT multiplanar reconstruction demonstrates a nonsignificant luminal narrowing in the mid LAD (arrow), and when short axis was evaluated the lesion fulfills 
noncalcified plaque features (arrowhead); B and C: ICA: The same nonobstructive lesion is observed in mid-LAD (arrow), which seems hyperlucent on LAO cranial 
projection (C); D: OCT confirms the presence of a red intracoronary thrombus (T) in the same location. CCT: Coronary computed tomography; LAD: Left anterior 
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Framingham risk score, prior cardiovascular events 
and angina. Lastly, new tracers targeted against other 
markers of inflammation such as macrophage infiltration 
(11C­PK11195[104] and 68Ga­DOTATATE[105]) have been 
successfully tested.
CONCLUSION
Noninvasive imaging tools have shown their capacity 
to detect features related with vulnerable coronary 
after stent implantation, a higher FDG uptake was 
noted not only in the culprit lesions but also in the left 
main and ascending thoracic aorta of the patients with 
acute coronary events (Figure 7)[102]. This suggests the 
presence of spread arterial wall inflammation in the 
former group. Conversely, Dweck et al[103] demonstrated 
the ability of the new tracer 18F­sodium fluoride to 
detect coronary atherosclerosis without the limitation 
of myocardial metabolism artifact. Increased uptake 
was also associated with coronary calcium score, 
Pozo E et al . Vulnerable plaque diagnosis
Figure 5  Unenhanced Whole-Heart coronary cardiac magnetic resonance angiography. Correlation of unenhanced whole-heart coronary CMR angiography 
(A, maximum intensity projection image, and B, volume-rendered image) with invasive coronary angiography (C) in a in a 50-year-old male patient with chest pain 
on effort. Note the presence of significant stenosis in proximal LAD (arrows). Adapted with permisssion from Nagata et al[75]. LAD: Left anterior descending coronary 






Figure 6  T1 hyperintense coronary plaques in cardiac magnetic resonance. Noninvasive and invasive coronary imaging of a significant plaque in proximal LAD. 
CCTA (A) showed a noncalcified plaque in LAD causing significant stenosis. When noncontrast T1-weighted CMR imaging was performed (B) a hyperintense lesion 
was detected. Afterwards, CMR images were fused with CCTA (C and D) and this lesion was found to correspond with the previously described coronary stenosis. 
Interestingly, during the subsequent coronary angiography it showed a large lipid component in IVUS (E) as well as OCT (F). Adapted with permission from Asaumi 
et al[106]. LAD: Left anterior descending coronary artery; CCTA: Coronary computed tomography; CMR: Cardiac magnetic resonance; IVUS: Intravascular ultrasound; 
OCT: Optical coherence tomography; PMR: Plaque to myocardium signal intensity ratio.
PMR = 2.5
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